Comparative effects of the dual metallopeptidase inhibitor, MDL 100,240 and of enalaprilat on regional and on cardiac haemodynamics in conscious, hypertensive, transgenic ((mRen-2)27) rats

British Journal of Pharmacology
S M GardinerT Bennett

Abstract

1. Heterozygous, male, hypertensive, transgenic ((mRen-2)27) rats (350-450 g) were instrumented for the measurement of regional or cardiac haemodynamics (n = 16, in both groups). Animals were given continuous i.v. infusions of the angiotensin-converting enzyme inhibitor, enalaprilat, or the dual metallopeptidase inhibitor, MDL 100,240 (both at 3 mg kg-1, 3 mg kg-1 h-1; n = 8 for regional and cardiac haemodynamics), for 32 h. Twenty four hours after the onset of infusion of enalaprilat or MDL 100,240, the bradykinin (B2)-receptor antagonist, Hoe 140 (1 mg kg-1, i.v.), was given and measurements were continued for a further 8 h, to assess any possible involvement of bradykinin. 2. Over the first 8 h of infusion, both enalaprilat and MDL 100,240 had significant antihypertensive effects, accompanied by similar regional vasodilatations. However, the blood pressure lowering effect of MDL 100,240 (-54 +/- 9 mmHg) was greater than that of enalaprilat (-38 +/- 4 mmHg), because the former caused a significantly greater reduction in cardiac index. 3. Between 8-24 h after the onset of infusion, there was a reduction in the effect of enalaprilat on blood pressure, because cardiac index rose, with no further increase in total peripheral cond...Continue Reading

References

Mar 1, 1991·British Journal of Pharmacology·K WirthJ Knolle
Jan 1, 1990·Journal of Cardiovascular Pharmacology·E G Erdös
Mar 1, 1991·Journal of Cardiovascular Pharmacology·A A SeymourB Abboa-Offei
Jul 23, 1991·European Journal of Pharmacology·G BaoT Unger
Oct 1, 1990·Hypertension·L DanckwardtT Unger
Jul 1, 1995·Journal of Cardiovascular Pharmacology·J F FrenchR C Dage
Oct 14, 1994·Biochemical and Biophysical Research Communications·S De LombaertR L Webb
Apr 26, 1994·Proceedings of the National Academy of Sciences of the United States of America·M C Fournié-ZaluskiJ B Michel
Jul 1, 1997·British Journal of Clinical Pharmacology·D J Webb

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.